(Equal to or greater than the cost of membership)

If you are not already a member, join now to receive the SRS member discount. And if you are a member, please renew now for 2017.

In addition to Nomenclature Guidance for ISRS 2017 Abstract Submission, the Working Group on Nomenclature in Radiopharmaceutical Chemistry has nearly completed development on a master document that will provide comprehensive and standardized guidance. The comprehensive document will be available via a link from this page very soon.

The Working Group was assembled in 2015 with the aim to generate a consensus for the utilization of a standardized nomenclature for the field. The initiative was triggered by the 'Drug Development Committee' of the EANM together with experts active at a host of relevant scientific societies (EANM, SRS, SNMMI and several national societies). 

Members: Click Here to modify/update your member profile.

Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.

Welcome to the website of the Society of Radiopharmaceutical Sciences!

Our primary goal for this website is to make it a useful resource for SRS members and non-members. Some content is accessible to members only. Members should login to the site through the authentication area at the top of this page. Your SRS profile email address and password are required. Non-members are invited to browse all but the Member Resources page to learn more about the SRS and the field.

ISRS 2017 will be held in May of next year, and the abstract submission system is now open. The abstract submission deadline is November 14, 2016. To learn more about this meeting, select the image below.

Special Guidance for Those Submitting Abstracts to ISRS 2017 in Dresden
SRS leadership and ISRS 2017 organizers strongly promote referencing the four-page PDF file: Nomenclature Guidance for ISRS 2017 Abstract Submission. This summary is a short version of the comprehensive document written by the Working Group on Nomenclature in Radiopharmaceutical Chemistry. The aim was to generate a consensus for the utilization of a standardized nomenclature for the field. For more information about the Working Group and the comprehensive document, refer to the sidebar on the right side of this page.